Trial
NCT02815059
Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Utah
Collaborators
Janssen, LP
Condition
Acute Lymphoblastic Leukemia
Intervention
Ibrutinib
Why stopped
Termination of Investigator Initiated Studies using Ibrutinib
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-31